1 - 25 of
49
results
for author:"Yamamoto J."
in Literature Citations
| Lack of kainic acid-induced gamma oscillations predicts subsequent CA1 excitotoxic cell death. Jinde S., Belforte J.E., Yamamoto J., Wilson M.A., Tonegawa S., Nakazawa K. Eur. J. Neurosci. 30:1036-1055(2009) · Mapped (2) |
| Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Nothlings U., Yamamoto J.F., Wilkens L.R., Murphy S.P., Park S.Y., Henderson B.E., Kolonel L.N., Le Marchand L. Cancer Epidemiol. Biomarkers Prev. 18:2098-2106(2009) · Mapped (19) |
| Functional motifs in the (6-4) photolyase crystal structure make a comparative framework for DNA repair photolyases and clock cryptochromes. Hitomi K., DiTacchio L., Arvai A.S., Yamamoto J., Kim S.T., Todo T., Tainer J.A., Iwai S., Panda S., Getzoff E.D. Proc. Natl. Acad. Sci. U.S.A. 106:6962-6967(2009) · Mapped (2) |
| Involvement of transient receptor potential vanilloid subfamily 1 in endothelin-1-induced pain-like behavior. Kawamata T., Ji W., Yamamoto J., Niiyama Y., Furuse S., Omote K., Namiki A. Neuroreport 20:233-237(2009) · Mapped (2) |
| Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. Sakakibara I., Fujino T., Ishii M., Tanaka T., Shimosawa T., Miura S., Zhang W., Tokutake Y., Yamamoto J., Awano M. et al. |
| SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Shikauchi Y., Saiura A., Kubo T., Niwa Y., Yamamoto J., Murase Y., Yoshikawa H. Mol. Cell. Biol. 29:1944-1958(2009) · Mapped (7) |
| Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer. Ueda S., Kondoh N., Tsuda H., Yamamoto S., Asakawa H., Fukatsu K., Kobayashi T., Yamamoto J., Tamura K., Ishida J. et al. BMC Cancer 8:384-384(2008) · Mapped (2) |
| Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R., Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T. et al. Nat. Methods 5:1011-1017(2008) · UniProtKB (38) |
| Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Kawamata T., Ji W., Yamamoto J., Niiyama Y., Furuse S., Namiki A. Neuroscience 154:1067-1076(2008) · Mapped (2) |
| Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Saltzman B.S., Yamamoto J.F., Decker R., Yokochi L., Theriault A.G., Vogt T.M., Le Marchand L. Cancer Res. 68:1236-1244(2008) · Mapped (9) |
| NELF interacts with CBC and participates in 3' end processing of replication-dependent histone mRNAs. Narita T., Yung T.M., Yamamoto J., Tsuboi Y., Tanabe H., Tanaka K., Yamaguchi Y., Handa H. Mol. Cell 26:349-365(2007) · Mapped (30) |
| CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma. Kameoka J., Ichinohasama R., Inoue H., Yamamoto J., Yokoyama H., Tomiya Y., Yamada M., Ishizawa K., Harigae H., Sawai T. et al. Leuk. Lymphoma 47:2181-2188(2006) · Mapped (23) |
| Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Ohshiro Y., Ma R.C., Yasuda Y., Hiraoka-Yamamoto J., Clermont A.C., Isshiki K., Yagi K., Arikawa E., Kern T.S., King G.L. Diabetes 55:3112-3120(2006) · Mapped (1) |
| Immunohistochemical analysis of acid-sensing ion channel 2 expression in rat dorsal root ganglion and effects of axotomy. Kawamata T., Ninomiya T., Toriyabe M., Yamamoto J., Niiyama Y., Omote K., Namiki A. Neuroscience 143:175-187(2006) · Mapped (1) |
| Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia. Abe S., Funato T., Takahashi S., Yokoyama H., Yamamoto J., Tomiya Y., Yamada-Fujiwara M., Ishizawa K., Kameoka J., Kaku M. et al. Tohoku J. Exp. Med. 209:217-228(2006) · Mapped (8) |
| Involvement of calcineurin-dependent degradation of Yap1p in Ca2+-induced G2 cell-cycle regulation in Saccharomyces cerevisiae. Yokoyama H., Mizunuma M., Okamoto M., Yamamoto J., Hirata D., Miyakawa T. EMBO Rep. 7:519-524(2006) · Mapped (10) |
| Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T., Yamashita R., Yamamoto J., Sekine M., Tsuritani K., Wakaguri H. et al. |
| Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries. Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J., Wakamatsu A., Kimura K., Sakamoto K., Hatano N. et al. DNA Res. 12:117-126(2005) · UniProtKB (310) |
| Adiponectin acts as an endogenous antithrombotic factor. Kato H., Kashiwagi H., Shiraga M., Tadokoro S., Kamae T., Ujiie H., Honda S., Miyata S., Ijiri Y., Yamamoto J. et al. Arterioscler. Thromb. Vasc. Biol. 26:224-230(2006) · Mapped (3) |
| Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Niwa Y., Kanda H., Shikauchi Y., Saiura A., Matsubara K., Kitagawa T., Yamamoto J., Kubo T., Yoshikawa H. Oncogene 24:6406-6417(2005) · Mapped (12) |
| Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate. Pu R., Coleman J., Coisman J., Sato E., Tanabe T., Arai M., Yamamoto J.K. J. Feline Med. Surg. 7:65-70(2005) · UniProtKB (3) |
| Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression. Nakayama H., Ihara K., Hikino S., Yamamoto J., Nagatomo T., Takemoto M., Hara T. J. Mol. Med. 83:316-320(2005) · Mapped (9) |
| MICA polymorphism in a sample of the Sao Paulo population, Brazil. Marin M.L., Savioli C.R., Yamamoto J.H., Kalil J., Goldberg A.C. Eur. J. Immunogenet. 31:63-71(2004) · Mapped (1,430) |
| A Kruppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2. Yamamoto J., Ikeda Y., Iguchi H., Fujino T., Tanaka T., Asaba H., Iwasaki S., Ioka R.X., Kaneko I.W., Magoori K. et al. J. Biol. Chem. 279:16954-16962(2004) · Mapped (5) |
| Complete sequencing and characterization of 21,243 full-length human cDNAs. Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K. et al. Nat. Genet. 36:40-45(2004) · UniProtKB (11,439) · Mapped (2) |
